Navigation Links
PROVENGE Significantly Prolongs Survival in Men With Advanced Prostate Cancer in Pivotal Phase 3 IMPACT Study
Date:4/14/2009

- Study Meets Primary Endpoint Showing Statistically Significant Improvement in Overall Survival -

- First Active Immunotherapy for Cancer to Prolong Survival -

- Full Data to be Presented at Plenary Session at Upcoming AUA Annual Meeting -

- Company to Host a Conference Call Today at 9:00 AM ET -

SEATTLE, April 14 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) announced today that the pivotal Phase 3 IMPACT study of PROVENGE(R) (sipuleucel-T) in men with advanced prostate cancer met its primary endpoint of improving overall survival compared to a placebo control. The magnitude of the survival difference observed in the intent to treat population resulted in the study successfully achieving the pre-specified level of statistical significance defined by the study's design. The safety profile of PROVENGE appeared to be consistent with prior trials.

The 512-patient, multi-center, randomized, double-blind, placebo-controlled IMPACT (IMmunotherapy for Prostate AdenoCarcinoma Treatment) study enrolled men with metastatic androgen-independent prostate cancer was conducted under a Special Protocol Assessment agreement with the U.S. Food and Drug Administration (FDA).

PROVENGE is Dendreon's investigational product candidate for men with advanced prostate cancer and may represent the first in a new class of active cellular immunotherapies specifically designed to engage the patient's own immune system against cancer.

Detailed results from the IMPACT study will be presented during a plenary session at the American Urological Association's Annual Meeting in Chicago on Tues., Apr. 28 at 2:20 pm CT.

"Survival is the gold standard outcome for oncology clinical trials, and overall survival
'/>"/>

SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer
2. FDA Agrees to Amend Dendreons Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
3. Pressure BioSciences, Inc. Reports Record Revenue, Significantly Reduced Operating Loss for the Fourth Quarter of 2008
4. New Multi-Center Study Finds Masimo SET Pulse Oximetry Screening Significantly Improves Detection of Congenital Heart Disease in Newborns
5. Epilepsia Study Demonstrates New Add-on Antiepileptic Drug Vimpat(R) (lacosamide) Significantly Reduces Partial-Onset Seizures in Adults With Epilepsy
6. Study Shows Machine Perfusion Significantly Improves Transplant Results
7. Anesiva Phase 3 Trial of Adlea Meets Primary Endpoint to Significantly Reduce Pain After Total Knee Replacement Surgery
8. Bucindolol Significantly Reduces Hospitalization and Death in Heart Failure Patients With Very Favorable Genotypes
9. Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
10. On the boil: New nano technique significantly boosts boiling efficiency
11. Phase 3 studies show golimumab significantly improved signs and symptoms of rheumatoid arthritis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... , Former Majority Leader Richard Gephardt ...Medicine, Biotech Communities for "Best and Brigh...ITY, N.J., Dec. 1 Sever...armaceuticals, research, medicine and technology g...cuss the importance of medical innovation in New J...
(Date:12/1/2009)... , SARASOTA, Fla., Dec. 1 Expa...sprey Biotechnics Inc. of Sarasota has appointed L...utor. ,, Lake is located near Birmingham, Engl...bacteria which serve the agricultural, waste water... to be hungry and to open drain fields, and clean ...
(Date:12/1/2009)..., SAN FRANCISCO, Dec. 1 The Bur...ost half the value it lost in October. The Select,...cellent month for the general markets with the Dow...alue. The gains held firm in the final two trading...sluggish Thanksgiving holiday shopping and Dubai,s...
(Date:12/1/2009)... EpiVax, Inc. today announced a ...RO, ROG; OTCQX: RHHBY) aimed at evaluating EpiVax&...uld potentially reduce detrimental immune response...Vax collaboration, the EpiVax Tregitope technology...nicity of protein therapeutics. , ...
Breaking Biology Technology:New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5Biotech Gets Back on Track in November 2Biotech Gets Back on Track in November 3Biotech Gets Back on Track in November 4EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3
... Lets Get Serious Column that first appeared on T...timulated a great deal of mail with healthy debate.... Here is another look at the same topic that shou...es can be reached at john@wistechnology.com . , ... impressions gleaned from my editorial, I am not a...
... relies on off-the-shelf chips, open-source OS , ...con Graphics Corp. (SGI) in more ways than one. , ...e scrambles to push product out the back door in t...oping earnestly that the market for its latest fla...d superclusters, can carry it back to profitabilit...
...y had the opportunity to discuss the role of techn...t information technology based services - internal...lso commented on programs to help entrepreneurs wi...o shared his thoughts on the challenges government... , , WTN: How can the state use technology to ru...
Other Biology Technology:Lets Get Serious: Another Look 2Lets Get Serious: Another Look 3SGI banking on Altix to pay the freight 2SGI banking on Altix to pay the freight 3WTN Interview with Governor Doyle 2WTN Interview with Governor Doyle 3WTN Interview with Governor Doyle 4WTN Interview with Governor Doyle 5WTN Interview with Governor Doyle 6
(Date:11/30/2009)...inaugural Global Conference on Systems & Enterpris...ngton, DC, focuses on the convergence of complex l...ortance to society. , The goal of the confer...around targeted complex systems, examined by domai...es Critical Infrastructure Systems, including Inte...
(Date:11/30/2009)...er early bird registration rates and register onli...010 at http://www.iofwco-ecceo10.org/ , WHAT:...ational Osteoporosis Foundation (IOF) and the Euro...Osteoporosis and Osteoarthritis (ESCEO). More than...cted to attend. The exciting scientific programme ...
(Date:11/30/2009)... published in the December 2009 print issue of The...pe of control over their fertility that women have...ve found how and where androgenic hormones work in... male fertility. This opens a promising avenue for...ery also offers hope to those who cannot have chil...
Breaking Biology News(10 mins):First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Ability to literally imagine oneself in anothers shoes may be tied to empathy 8966 1Ability to literally imagine oneself in anothers shoes may be tied to empathy 8966 2Ability to literally imagine oneself in anothers shoes may be tied to empathy 8966 3Rotary Marks Progress in Drive to Eradicate Polio 49766 1Rotary Marks Progress in Drive to Eradicate Polio 49766 2Rotary Marks Progress in Drive to Eradicate Polio 49766 3BCBSNC Sees Improved Health Quality Lower Costs Through Financial Rewards to Physicians 49763 1BCBSNC Sees Improved Health Quality Lower Costs Through Financial Rewards to Physicians 49763 2BCBSNC Sees Improved Health Quality Lower Costs Through Financial Rewards to Physicians 49763 3BCBSNC Sees Improved Health Quality Lower Costs Through Financial Rewards to Physicians 49763 4
...cky has been honored for his role in the developme...soldiers who suffer severe, life-threatening injur... Defense,s Advanced Technology Applications for Co...ugust 11 during the opening ceremonies of the grou...on is the premier scientific meeting on the battle...
...f Oregon, towering king of old-growth forests and ...stops growing taller because it just can,t pull wa...it on height is somewhere above 350 feet, or talle... tradeoff between two factors in the tree,s wood -...orting water to the uppermost leaves. , The findi...
...at, when a tree falls near a city street, it makes...o answer: Who is affected by the falling tree and ...onsible for deciding how to replace the tree? , ... and doctoral student, and presented at two intern...t trees as a "common-pool resource" can help lead ...
Other Biology News:UCSB chemistry professor receives top military award for life-saving gauze 2UCSB chemistry professor receives top military award for life-saving gauze 3Old growth giants limited by water-pulling ability 2Old growth giants limited by water-pulling ability 3If a street tree falls... what does it take to make sound policy? 2If a street tree falls... what does it take to make sound policy? 3
Chlamydia trachomatis IgM ELISA Kit, Single from Bio-Quant Inc.
H. Pylori IgM ELISA Kit, Single from Bio-Quant Inc.
Mouse IgE ELISA Kit from Bethyl Laboratories
Mouse IgM EIA Kit from Assay Designs/Stressgen Bioreagents
Biology Products: